Perphenazine in Host-Pathogen Research: Mechanisms and Proto
2026-05-20
Explore Perphenazine as a dopamine D2 receptor antagonist for advanced host-pathogen interaction research. This article uniquely dissects its ROS- and autophagy-mediated antibacterial actions, with protocol guidance and deep cross-domain insight.
Aromatase (CYP19) Inhibition by Lamotrigine and Other AEDs
2026-05-19
This study systematically evaluated the ability of twelve antiepileptic drugs, including Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine), to inhibit human aromatase (CYP19). The findings reveal direct CYP19 inhibition by select AEDs and highlight implications for hormonal balance in epilepsy therapy. These insights inform preclinical study design and mechanistic understanding of endocrine side effects.
PTPN2 Modulation of the STING–STAT3 Axis Restores Autophagy
2026-05-19
This study uncovers how PTPN2 alleviates psoriasis by targeting the STING–STAT3 pathway and enhancing autophagy and apoptosis in keratinocytes. These insights offer a mechanistic basis for new therapeutic strategies that directly modulate epithelial cell signaling in immune-mediated skin disease.
PKH26 Red Fluorescent Cell Linker Kit: Technical Lab Guidanc
2026-05-18
The PKH26 Red Fluorescent Cell Linker Kit provides a robust, minimally toxic method for labeling cell membrane lipid regions, supporting reliable cell tracing and proliferation detection in both in vitro and in vivo research. It should be used exclusively for membrane-specific applications and not for intracellular or non-membrane targets.
Mubritinib (TAK 165): Protocol-Driven Advances in Cancer Res
2026-05-18
Mubritinib (TAK 165) enables researchers to precisely target mitochondrial complex I and disrupt cancer cell metabolism in models of chemotherapy-resistant acute myeloid leukemia (AML) and primary effusion lymphoma (PEL). This article translates latest reference study breakthroughs into actionable workflows, troubleshooting insights, and protocol enhancements for applied cancer biology.
BAPTA Calcium Chelator: Enhancing Apoptosis & Signaling Assa
2026-05-17
BAPTA empowers precise dissection of calcium-dependent signaling pathways, transforming apoptosis and cell toxicity workflows. This guide translates cutting-edge environmental exposure research into practical protocols, troubleshooting strategies, and assay optimizations for advanced cellular studies.
Gamithromycin: Optimizing Respiratory Pathogen Assays and PK
2026-05-16
Gamithromycin (ML-1709460) offers unparalleled efficacy for in vitro and in vivo modeling of veterinary respiratory pathogens, with superior lung tissue targeting and serum-potentiated activity. This article delivers actionable protocols, advanced troubleshooting, and benchmarking insights for maximizing translational impact, leveraging APExBIO’s validated formulation.
Zoledronic Acid as a Nitrogen-Containing Bisphosphonate in E
2026-05-15
Zoledronic Acid empowers researchers to interrogate cancer cell apoptosis and bone disease by modulating ECM turnover and mitochondrial pathways. This guide leverages recent multiomics breakthroughs and APExBIO’s trusted reagent quality to enable robust, reproducible experimental workflows.
Sulfo-Cy3 NHS Ester: Hydrophilic Dye for Precise Protein Lab
2026-05-15
Sulfo-Cy3 NHS Ester from APExBIO delivers unmatched hydrophilicity and minimized quenching, enabling robust fluorescent labeling even for challenging, low-solubility proteins. Its workflow flexibility and quantitative reliability make it a top-tier choice for translational research in vascular biology and advanced cell imaging.
Optimizing Cell Proliferation Assays with Cell Counting Kit-
2026-05-14
Cell Counting Kit-8 (CCK-8) sets a new standard for sensitive, reproducible cell viability and cytotoxicity assays, as showcased in recent immunology and cancer research. This article delivers workflow enhancements, troubleshooting strategies, and direct insights from benchmark studies, empowering users to maximize data reliability and throughput.
AT13387: Hsp90 Inhibitor Workflows in Cancer Biology Researc
2026-05-14
AT13387 delivers robust, reproducible Hsp90 inhibition with nanomolar potency, enabling precise modulation of oncogenic signaling and apoptosis in cancer biology research. Learn how this orally bioavailable inhibitor empowers advanced workflows, troubleshooting, and protocol optimization for both in vitro and in vivo models.
Gamithromycin: PK/PD-Driven Dose Optimization for Animal Res
2026-05-13
Explore how Gamithromycin, a potent ML-1709460 macrolide, enables precision dosing and resistance monitoring in animal respiratory disease research. This article integrates cutting-edge PK/PD insights to inform advanced assay design and translational applications.
Synergistic Action of Trimethoprim-Sulfonamide Combinations
2026-05-13
This study systematically evaluates the in vitro efficacy of trimethoprim (TMP) combined with various sulfonamides against equine Salmonella isolates, demonstrating pronounced synergy—especially for sulfadiazine, sulfachlorpyridazine, and sulfamethoxazole. The findings inform optimal antimicrobial combinations and underscore the importance of susceptibility testing in veterinary infectious disease management.
Palomid 529 (P529): Enabling Precision PI3K/Akt/mTOR Pathway
2026-05-12
Explore how Palomid 529 (P529) empowers translational cancer research by precisely inhibiting the PI3K/Akt/mTOR pathway, with a unique focus on integrating RCN2-driven resistance mechanisms and practical assay design. This article provides in-depth scientific insight and protocol guidance, distinguishing it from previous overviews.
AG-490 (Tyrphostin B42): Dissecting JAK2/STAT6 Modulation in
2026-05-12
Explore how AG-490 (Tyrphostin B42) enables precise, mechanistic dissection of the JAK2/STAT6 axis in tumor-associated macrophage polarization. This article uniquely bridges exosomal snoRNA biology and advanced immunopathology, offering actionable insights for cancer research.
457 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page